MERIT MEDICAL SYSTEMS INC financials

  1. Home
  2. Financials
  3. MMSI
MMSI CIK 0000856982

Source: EDGAR filings · Built 2026-06-02T03:34:17Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 215.66M 185.66M 110.86M 69.26M 119.29M 119.28M
EBITDA 307.89M 258.40M 213.93M 169.37M 144.98M 92.51M
Working Capital 800.39M 707.37M 904.91M 308.44M 245.93M 244.70M
Net Debt 375.17M 417.95M 304.32M 210.34M 247.28M 378.15M
Gross Margin 48.70% 47.43% 46.44% 45.10% 45.16% 41.62%
Operating Margin 12.19% 11.48% 9.86% 7.61% 5.67% -0.16%
Net Margin 8.48% 8.87% 7.51% 6.47% 4.51% -1.02%
Return on Equity (ROE) 8.11% 8.73% 7.85% 6.51% 4.66% -1.03%
Return on Assets (ROA) 4.78% 4.98% 4.06% 4.48% 2.94% -0.59%
Current Ratio 4.34× 4.27× 5.45× 2.40× 2.04× 2.32×
Debt-to-Equity 0.52× 0.58× 0.74× 0.23× 0.30× 0.45×
Effective Tax Rate 24.83% 19.76% 15.77% 9.82% 10.13% 25.61%
Cash Conversion Ratio 2.31× 1.83× 1.54× 1.53× 3.04× -16.79×
Accruals Ratio -0.06× -0.04× -0.02× -0.02× -0.06× -0.11×
SBC % of Revenue 2.87% 2.10% 1.70% 1.57% 1.50% 1.49%
CapEx Coverage 3.64× 6.28× 4.23× 2.54× 5.27× 3.59×
Free Cash Flow Per Share $3.57 $3.13 $1.90 $1.20 $2.08 $2.15

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 41.38× 47.65× 46.89× 54.74× 74.17× —
P/FCF 24.71× 30.93× 39.99× 58.80× 29.96× 25.80×
FCF Yield 4.05% 3.23% 2.50% 1.70% 3.34% 3.88%
EV / EBITDA 18.23× 23.61× 21.97× 25.14× 26.01× 37.46×
P/S 3.46× 4.19× 3.50× 3.52× 3.28× 3.20×
P/B 3.31× 4.12× 3.66× 3.54× 3.39× 3.22×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 1.52B 1.36B 1.26B 1.15B 1.07B 963.88M
Cost of Goods and Services Sold 777.64M 713.18M 673.49M 631.88M 589.42M 562.70M
Gross Profit 738.27M 643.33M 583.87M 519.10M 485.33M 401.18M
Selling, General and Administrative Expense 455.21M 399.73M 373.68M 342.52M 335.69M 297.72M
Operating Expenses 553.55M 487.64M 459.93M 431.54M 424.42M 402.74M
Operating Income (Loss) 184.72M 155.69M 123.94M 87.56M 60.92M -1.56M
Income Tax Expense (Benefit) 42.45M 29.64M 17.68M 8.11M 5.46M -3.39M
Net Income (Loss) Attributable to Parent 128.49M 120.36M 94.41M 74.52M 48.45M -9.84M
Earnings Per Share, Basic $2.17 $2.07 $1.64 $1.31 $0.86 $-0.18
Weighted Average Number of Shares Outstanding, Basic 59.16M 58.22M 57.59M 56.81M 56.15M 55.43M
Earnings Per Share, Diluted $2.13 $2.03 $1.62 $1.29 $0.84 $-0.18
Weighted Average Number of Shares Outstanding, Diluted 60.46M 59.37M 58.36M 57.67M 57.36M 55.43M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 446.40M 376.71M 587.04M 58.41M 67.75M 56.92M
Assets, Current 1.04B 923.77M 1.11B 529.08M 482.21M 429.71M
Assets 2.69B 2.42B 2.33B 1.66B 1.65B 1.66B
Long-term Debt 734.04M 729.55M 823.01M 198.01M 242.84M 351.22M
Liabilities, Current 239.76M 216.40M 203.56M 220.65M 236.28M 185.00M
Long-term Debt, Excluding Current Maturities 734.04M 729.55M 823.01M 186.76M 234.40M 343.72M
Liabilities 1.10B 1.04B 1.12B 519.57M 608.50M 705.82M
Stockholders' Equity Attributable to Parent 1.58B 1.38B 1.20B 1.14B 1.04B 958.58M
Common Stock, Shares, Outstanding 59.42M 58.74M 57.86M 57.31M 56.57M 55.62M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 297.37M 220.80M 145.15M 114.29M 147.23M 165.27M
Payments to Acquire Property, Plant, and Equipment 81.72M 35.14M 34.29M 45.03M 27.94M 45.99M
Net Cash Provided by (Used in) Investing Activities -247.39M -368.65M -175.35M -57.40M -37.16M -58.65M
Net Cash Provided by (Used in) Financing Activities 16.00M -60.01M 559.27M -60.26M -98.44M -95.71M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (MMSI CIK 0000856982), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

RYAM

RAYONIER ADVANCED MATERIALS INC.

BELFA

BEL FUSE INC /NJ

IEX

IDEX CORP